메뉴 건너뛰기




Volumn 10, Issue 2, 2015, Pages 141-155

Blood-brain barrier models: In vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics

Author keywords

Biomarkers; Blood brain barrier; in vitro blood brain barrier models; Stem cells

Indexed keywords

ANTIBODY; CENTRAL NERVOUS SYSTEM AGENTS; MONOCLONAL ANTIBODY;

EID: 84921485397     PISSN: 17460441     EISSN: 1746045X     Source Type: Journal    
DOI: 10.1517/17460441.2015.974545     Document Type: Review
Times cited : (67)

References (93)
  • 1
    • 84881296154 scopus 로고    scopus 로고
    • Trial watch: Phase II and phase III attrition rates 2011-2012
    • Arrowsmith J, Miller P. Trial watch: phase II and phase III attrition rates 2011-2012. Nat Rev Drug Discov 2013;12:569
    • (2013) Nat Rev Drug Discov , vol.12 , pp. 569
    • Arrowsmith, J.1    Miller, P.2
  • 4
    • 13244271912 scopus 로고    scopus 로고
    • Prediction of blood-brain barrier permeation in drug discovery from in vivo, in vitro and in silico models
    • Abbott NJ. Prediction of blood-brain barrier permeation in drug discovery from in vivo, in vitro and in silico models. Drug Discov Today Technol 2004;1:407-16
    • (2004) Drug Discov Today Technol , vol.1 , pp. 407-416
    • Abbott, N.J.1
  • 5
    • 79951922143 scopus 로고    scopus 로고
    • Engaging neuroscience to advance translational research in brain barrier biology
    • Neuwelt EA, Bauer B, Fahlke C, et al. Engaging neuroscience to advance translational research in brain barrier biology. Nat Rev Neurosci 2011;12:169-82
    • (2011) Nat Rev Neurosci , vol.12 , pp. 169-182
    • Neuwelt, E.A.1    Bauer, B.2    Fahlke, C.3
  • 6
    • 84887403996 scopus 로고    scopus 로고
    • Sealing off the CNS: Cellular and molecular regulation of blood-brain barriergenesis
    • Siegenthaler JA, Sohet F, Daneman R. "Sealing off the CNS": cellular and molecular regulation of blood-brain barriergenesis. Curr Opin Neurobiol 2013;23:1057-64
    • (2013) Curr Opin Neurobiol , vol.23 , pp. 1057-1064
    • Siegenthaler, J.A.1    Sohet, F.2    Daneman, R.3
  • 7
    • 84889872057 scopus 로고    scopus 로고
    • Development, maintenance and disruption of the blood-brain barrier
    • Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood-brain barrier. Nat Med 2013;19:1584-96
    • (2013) Nat Med , vol.19 , pp. 1584-1596
    • Obermeier, B.1    Daneman, R.2    Ransohoff, R.M.3
  • 8
    • 29244463365 scopus 로고    scopus 로고
    • Astrocyte-endothelial interactions at the blood-brain barrier
    • Abbott NJ, Rönnbäck L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006;7:41-53
    • (2006) Nat Rev Neurosci , vol.7 , pp. 41-53
    • Abbott, N.J.1    Rönnbäck, L.2    Hansson, E.3
  • 9
    • 80053548451 scopus 로고    scopus 로고
    • In vitro modeling of the blood-brain barrier: Simplicity versus complexity
    • Ogunshola OO. In vitro modeling of the blood-brain barrier: simplicity versus complexity. Curr Pharm Des 2011;17:2755-61
    • (2011) Curr Pharm des , vol.17 , pp. 2755-2761
    • Ogunshola, O.O.1
  • 10
    • 0033526177 scopus 로고    scopus 로고
    • In vitro model for evaluating drug transport across the blood-brain barrier
    • Cecchelli R, Dehouck B, Descamps L, et al. In vitro model for evaluating drug transport across the blood-brain barrier. Adv Drug Deliv Rev 1999;36:165-78
    • (1999) Adv Drug Deliv Rev , vol.36 , pp. 165-178
    • Cecchelli, R.1    Dehouck, B.2    Descamps, L.3
  • 11
    • 79959337016 scopus 로고    scopus 로고
    • Patented in vitro blood-brain barrier models in CNS drug discovery
    • Tóth A, Veszelka S, Nakagawa S, et al. Patented in vitro blood-brain barrier models in CNS drug discovery. Recent Pat CNS Drug Discov 2011;6:107-18
    • (2011) Recent Pat CNS Drug Discov , vol.6 , pp. 107-118
    • Tóth, A.1    Veszelka, S.2    Nakagawa, S.3
  • 12
    • 60949110463 scopus 로고    scopus 로고
    • A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes
    • Nakagawa S, Deli MA, Kawaguchi H, et al. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem Int 2009;54:253-63
    • (2009) Neurochem Int , vol.54 , pp. 253-263
    • Nakagawa, S.1    Deli, M.A.2    Kawaguchi, H.3
  • 13
    • 40249118217 scopus 로고    scopus 로고
    • An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening
    • Culot M, Lundquist S, Vanuxeem D, et al. An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening. Toxicol Vitr 2008;22:799-811
    • (2008) Toxicol Vitr , vol.22 , pp. 799-811
    • Culot, M.1    Lundquist, S.2    Vanuxeem, D.3
  • 14
    • 84860366574 scopus 로고    scopus 로고
    • Characterization of a microfluidic in vitro model of the bloodbrain barrier (μBBB)
    • Booth R, Kim H. Characterization of a microfluidic in vitro model of the bloodbrain barrier (μBBB). Lab Chip 2012;12:1784-92
    • (2012) Lab Chip , vol.12 , pp. 1784-1792
    • Booth, R.1    Kim, H.2
  • 15
    • 84872610509 scopus 로고    scopus 로고
    • BBB on chip: Microfluidic platform to mechanically and biochemically modulate blood-brain barrier function
    • Griep LM, Wolbers F, de Wagenaar B, et al. BBB on chip: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function. Biomed Microdevices 2013;15:145-50
    • (2013) Biomed Microdevices , vol.15 , pp. 145-150
    • Griep, L.M.1    Wolbers, F.2    De Wagenaar, B.3
  • 16
    • 84873255363 scopus 로고    scopus 로고
    • A new dynamic in vitro modular capillaries-venules modular system: Cerebrovascular physiology in a box
    • Cucullo L, Hossain M, Tierney W, Janigro D. A new dynamic in vitro modular capillaries-venules modular system: cerebrovascular physiology in a box. BMC Neurosci 2013;14:18
    • (2013) BMC Neurosci , vol.14 , pp. 18
    • Cucullo, L.1    Hossain, M.2    Tierney, W.3    Janigro, D.4
  • 17
    • 38549096764 scopus 로고    scopus 로고
    • Immortalized human brain endothelial cells and flow-based vascular modeling: A marriage of convenience for rational neurovascular studies
    • Cucullo L, Couraud P-O, Weksler B, et al. Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies. J Cereb Blood Flow Metab 2008;28:312-28
    • (2008) J Cereb Blood Flow Metab , vol.28 , pp. 312-328
    • Cucullo, L.1    Couraud, P.-O.2    Weksler, B.3
  • 18
    • 84867848663 scopus 로고    scopus 로고
    • Comparison of brain capillary endothelial cell-based and epithelial (MDCKMDR1, Caco-2, and VB-Caco-2) cellbased surrogate blood-brain barrier penetration models
    • Hellinger E, Veszelka S, Tóth AE, et al. Comparison of brain capillary endothelial cell-based and epithelial (MDCKMDR1, Caco-2, and VB-Caco-2) cellbased surrogate blood-brain barrier penetration models. Eur J Pharm Biopharm 2012;82:340-51
    • (2012) Eur J Pharm Biopharm , vol.82 , pp. 340-351
    • Hellinger, E.1    Veszelka, S.2    Tóth, A.E.3
  • 19
    • 13844299532 scopus 로고    scopus 로고
    • In vitro models for the blood-brain barrier
    • Garberg P, Ball M, Borg N, et al. In vitro models for the blood-brain barrier. Toxicol Vitr 2005;19:299-334
    • (2005) Toxicol Vitr , vol.19 , pp. 299-334
    • Garberg, P.1    Ball, M.2    Borg, N.3
  • 20
    • 34748815589 scopus 로고    scopus 로고
    • Pericytes from brain microvessels strengthen the barrier integrity in primary cultures of rat brain endothelial cells
    • Nakagawa S, Deli MA, Nakao S, et al. Pericytes from brain microvessels strengthen the barrier integrity in primary cultures of rat brain endothelial cells. Cell Mol Neurobiol 2007;27:687-94
    • (2007) Cell Mol Neurobiol , vol.27 , pp. 687-694
    • Nakagawa, S.1    Deli, M.A.2    Nakao, S.3
  • 21
    • 84879047058 scopus 로고    scopus 로고
    • Modelling the endothelial blood-CNS barriers: A method for the production of robust in vitro models of the rat blood-brain barrier and bloodspinal cord barrier
    • Watson PMD, Paterson JC, Thom G, et al. Modelling the endothelial blood-CNS barriers: a method for the production of robust in vitro models of the rat blood-brain barrier and bloodspinal cord barrier. BMC Neurosci 2013;14:59
    • (2013) BMC Neurosci , vol.14 , pp. 59
    • Watson, P.M.D.1    Paterson, J.C.2    Thom, G.3
  • 22
    • 20444415354 scopus 로고    scopus 로고
    • Mouse syngenic in vitro blood-brain barrier model: A new tool to examine inflammatory events in cerebral endothelium
    • Coisne C, Dehouck L, Faveeuw C, et al. Mouse syngenic in vitro blood-brain barrier model: a new tool to examine inflammatory events in cerebral endothelium. Lab Investig 2005;85:734-46
    • (2005) Lab Investig , vol.85 , pp. 734-746
    • Coisne, C.1    Dehouck, L.2    Faveeuw, C.3
  • 23
    • 84879317981 scopus 로고    scopus 로고
    • Establishment of a simplified in vitro porcine blood-brain barrier model with high transendothelial electrical resistance
    • Patabendige A, Skinner RA, Abbott NJ. Establishment of a simplified in vitro porcine blood-brain barrier model with high transendothelial electrical resistance. Brain Res 2013;1521:1-15
    • (2013) Brain Res , vol.1521 , pp. 1-15
    • Patabendige, A.1    Skinner, R.A.2    Abbott, N.J.3
  • 24
    • 84899917684 scopus 로고    scopus 로고
    • T-PA, but not desmoteplase, induces plasmin-dependent opening of a blood-brain barrier model under normoxic and ischaemic conditions
    • Freeman R, Niego B, R Croucher D, et al. t-PA, but not desmoteplase, induces plasmin-dependent opening of a blood-brain barrier model under normoxic and ischaemic conditions. Brain Res 2014;1565:63-73
    • (2014) Brain Res , vol.1565 , pp. 63-73
    • Freeman, R.1    Niego, B.2    Croucher, D.3
  • 25
    • 0036480118 scopus 로고    scopus 로고
    • Selection of phagedisplayed llama single-domain antibodies that transmigrate across human bloodbrain barrier endothelium
    • Muruganandam A, Tanha J, Narang S, Stanimirovic D. Selection of phagedisplayed llama single-domain antibodies that transmigrate across human bloodbrain barrier endothelium. FASEB J 2002;16:240-2
    • (2002) FASEB J , vol.16 , pp. 240-242
    • Muruganandam, A.1    Tanha, J.2    Narang, S.3    Stanimirovic, D.4
  • 26
    • 84887444174 scopus 로고    scopus 로고
    • GRL-04810 and GRL-05010, difluoride-containing nonpeptidic HIV-1 protease inhibitors (PIs) that inhibit the replication of multi-PI-resistant HIV-1 in vitro and possess favorable lipophilicity that may allow blood-brain barrier penetration
    • Salcedo Gómez PM, Amano M, Yashchuk S, et al. GRL-04810 and GRL-05010, difluoride-containing nonpeptidic HIV-1 protease inhibitors (PIs) that inhibit the replication of multi-PI-resistant HIV-1 in vitro and possess favorable lipophilicity that may allow blood-brain barrier penetration. Antimicrob Agents Chemother 2013;57:6110-21
    • (2013) Antimicrob Agents Chemother , vol.57 , pp. 6110-6121
    • Salcedo Gómez, P.M.1    Amano, M.2    Yashchuk, S.3
  • 27
    • 0025063772 scopus 로고
    • Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene
    • Montesano R, Pepper MS, Möhle-Steinlein U, et al. Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene. Cell 1990;62:435-45
    • (1990) Cell , vol.62 , pp. 435-445
    • Montesano, R.1    Pepper, M.S.2    Möhle-Steinlein, U.3
  • 28
    • 0028024646 scopus 로고
    • Regulation of gammaglutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells
    • Roux F, Durieu-Trautmann O, Chaverot N, et al. Regulation of gammaglutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells. J Cell Physiol 1994;159:101-13
    • (1994) J Cell Physiol , vol.159 , pp. 101-113
    • Roux, F.1    Durieu-Trautmann, O.2    Chaverot, N.3
  • 29
    • 0030726926 scopus 로고    scopus 로고
    • Development of immortalized human cerebromicrovascular endothelial cell line as an in vitro model of the human blood-brain barrier
    • Muruganandam A, Herx LM, Monette R, et al. Development of immortalized human cerebromicrovascular endothelial cell line as an in vitro model of the human blood-brain barrier. FASEB J 1997;11:1187-97
    • (1997) FASEB J , vol.11 , pp. 1187-1197
    • Muruganandam, A.1    Herx, L.M.2    Monette, R.3
  • 30
    • 27744460321 scopus 로고    scopus 로고
    • Blood-brain barrier-specific properties of a human adult brain endothelial cell line
    • Weksler BB, Subileau EA, Perrière N, et al. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 2005;19:1872-4
    • (2005) FASEB J , vol.19 , pp. 1872-1874
    • Weksler, B.B.1    Subileau, E.A.2    Perrière, N.3
  • 31
    • 84876161205 scopus 로고    scopus 로고
    • The hCMEC/D3 cell line as a model of the human blood brain barrier
    • Weksler B, Romero IA, Couraud PO. The hCMEC/D3 cell line as a model of the human blood brain barrier. Fluids Barriers CNS 2013;10:16
    • (2013) Fluids Barriers CNS , vol.10 , pp. 16
    • Weksler, B.1    Romero, I.A.2    Couraud, P.O.3
  • 32
    • 84872178048 scopus 로고    scopus 로고
    • Laminin isoforms in endothelial and perivascular basement membranes
    • Yousif LF, Di Russo J, Sorokin L. Laminin isoforms in endothelial and perivascular basement membranes. Cell Adh Migr 2013;7:101-10
    • (2013) Cell Adh Migr , vol.7 , pp. 101-110
    • Yousif, L.F.1    Di Russo, J.2    Sorokin, L.3
  • 33
    • 33947723274 scopus 로고    scopus 로고
    • The impact of glia-derived extracellular matrices on the barrier function of cerebral endothelial cells: An in vitro study
    • Hartmann C, Zozulya A, Wegener J, Galla HJ. The impact of glia-derived extracellular matrices on the barrier function of cerebral endothelial cells: an in vitro study. Exp Cell Res 2007;313:1318-25
    • (2007) Exp Cell Res , vol.313 , pp. 1318-1325
    • Hartmann, C.1    Zozulya, A.2    Wegener, J.3    Galla, H.J.4
  • 34
    • 67249117305 scopus 로고    scopus 로고
    • Control of the blood-brain barrier by glucocorticoids and the cells of the neurovascular unit
    • Kröll S, El-Gindi J, Thanabalasundaram G, et al. Control of the blood-brain barrier by glucocorticoids and the cells of the neurovascular unit. Ann N Y Acad Sci 2009;1165:228-39
    • (2009) Ann N y Acad Sci , vol.1165 , pp. 228-239
    • Kröll, S.1    El-Gindi, J.2    Thanabalasundaram, G.3
  • 35
    • 27844518332 scopus 로고    scopus 로고
    • The critical component to establish in vitro BBB model: Pericyte
    • Lai CH, Kuo KH, The critical component to establish in vitro BBB model: pericyte. Brain Res Brain Res Rev 2005;50:258-65
    • (2005) Brain Res Brain Res Rev , vol.50 , pp. 258-265
    • Lai, C.H.1    Kuo, K.H.2
  • 36
    • 17644364388 scopus 로고    scopus 로고
    • Dynamics of CNS barriers: Evolution, differentiation, and modulation
    • Abbott NJ. Dynamics of CNS barriers: evolution, differentiation, and modulation. Cell Mol Neurobiol 2005;25:5-23
    • (2005) Cell Mol Neurobiol , vol.25 , pp. 5-23
    • Abbott, N.J.1
  • 37
    • 84881180266 scopus 로고    scopus 로고
    • Wnt activation of immortalized brain endothelial cells as a tool for generating a standardized model of the blood brain barrier in vitro
    • Paolinelli R, Corada M, Ferrarini L, et al. Wnt activation of immortalized brain endothelial cells as a tool for generating a standardized model of the blood brain barrier in vitro. PLoS One 2013;8:e70233
    • (2013) PLoS One , vol.8 , pp. e70233
    • Paolinelli, R.1    Corada, M.2    Ferrarini, L.3
  • 38
    • 84872734009 scopus 로고    scopus 로고
    • Retinoic acid induces blood-brain barrier development
    • Mizee MR, Wooldrik D, Lakeman KAM, et al. Retinoic acid induces blood-brain barrier development. J Neurosci 2013;33:1660-71
    • (2013) J Neurosci , vol.33 , pp. 1660-1671
    • Mizee, M.R.1    Wooldrik, D.2    Lakeman, K.A.M.3
  • 39
    • 79953686193 scopus 로고    scopus 로고
    • Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors
    • Uchida Y, Ohtsuki S, Katsukura Y, et al. Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors. J Neurochem 2011;117:333-45
    • (2011) J Neurochem , vol.117 , pp. 333-345
    • Uchida, Y.1    Ohtsuki, S.2    Katsukura, Y.3
  • 40
    • 84901056306 scopus 로고    scopus 로고
    • Quantitative targeted proteomics for understanding the blood-brain barrier: Towards pharmacoproteomics
    • Ohtsuki S, Hirayama M, Ito S, et al. Quantitative targeted proteomics for understanding the blood-brain barrier: towards pharmacoproteomics. Expert Rev Proteomics 2014;11:303-13
    • (2014) Expert Rev Proteomics , vol.11 , pp. 303-313
    • Ohtsuki, S.1    Hirayama, M.2    Ito, S.3
  • 41
    • 79957439772 scopus 로고    scopus 로고
    • Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target
    • Yu YJ, Zhang Y, Kenrick M, et al. Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target. Sci Transl Med 2011;3:84ra44
    • (2011) Sci Transl Med , vol.3 , pp. 84ra44
    • Yu, Y.J.1    Zhang, Y.2    Kenrick, M.3
  • 42
    • 84878276906 scopus 로고    scopus 로고
    • Addressing safety liabilities of TfR bispecific antibodies that cross the bloodbrain barrier
    • Couch JA, Yu YJ, Zhang Y, et al. Addressing safety liabilities of TfR bispecific antibodies that cross the bloodbrain barrier. Sci Transl Med 2013;5(183):183ra571
    • (2013) Sci Transl Med , vol.5 , Issue.183 , pp. 183ra571
    • Couch, J.A.1    Yu, Y.J.2    Zhang, Y.3
  • 43
    • 0025837039 scopus 로고
    • Immortalization of brain capillary endothelial cells with maintenance of structural characteristics of the bloodbrain barrier endothelium
    • Durieu-Trautmann O, Foignant-Chaverot N, Perdomo J, et al. Immortalization of brain capillary endothelial cells with maintenance of structural characteristics of the bloodbrain barrier endothelium. Vitr Cell Dev Biol 1991;27A:771-8
    • (1991) Vitr Cell Dev Biol , vol.27 A , pp. 771-778
    • Durieu-Trautmann, O.1    Foignant-Chaverot, N.2    Perdomo, J.3
  • 44
    • 0035154799 scopus 로고    scopus 로고
    • Bacterial invasion and transcytosis in transfected human brain microvascular endothelial cells
    • Stins MF, Badger J, Sik Kim K. Bacterial invasion and transcytosis in transfected human brain microvascular endothelial cells. Microb Pathog 2001;30:19-28
    • (2001) Microb Pathog , vol.30 , pp. 19-28
    • Stins, M.F.1    Badger, J.2    Sik Kim, K.3
  • 45
    • 84887987425 scopus 로고    scopus 로고
    • Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies
    • Eigenmann DE, Xue G, Kim KS, et al. Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies. Fluids Barriers CNS 2013;10:33
    • (2013) Fluids Barriers CNS , vol.10 , pp. 33
    • Eigenmann, D.E.1    Xue, G.2    Kim, K.S.3
  • 46
    • 0030175172 scopus 로고    scopus 로고
    • Studies of Plasmodium falciparum cytoadherence using immortalized human brain capillary endothelial cells
    • Prudhomme JG, Sherman IW, Land KM, et al. Studies of Plasmodium falciparum cytoadherence using immortalized human brain capillary endothelial cells. Int J Parasitol 1996;26:647-55
    • (1996) Int J Parasitol , vol.26 , pp. 647-655
    • Prudhomme, J.G.1    Sherman, I.W.2    Land, K.M.3
  • 47
    • 3242656233 scopus 로고
    • Establishment of a line of human fetal glial cells that supports JC virus multiplication
    • Major EO, Miller AE, Mourrain P, et al. Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc Natl Acad Sci USA 1985;82:1257-61
    • (1985) Proc Natl Acad Sci USA , vol.82 , pp. 1257-1261
    • Major, E.O.1    Miller, A.E.2    Mourrain, P.3
  • 48
    • 78049231404 scopus 로고    scopus 로고
    • Peripheral nerve pericytes modify the blood-nerve barrier function and tight junctional molecules through the secretion of various soluble factors
    • Shimizu F, Sano Y, Abe M-A, et al. Peripheral nerve pericytes modify the blood-nerve barrier function and tight junctional molecules through the secretion of various soluble factors. J Cell Physiol 2011;226:255-66
    • (2011) J Cell Physiol , vol.226 , pp. 255-266
    • Shimizu, F.1    Sano, Y.2    Abe, M.-A.3
  • 49
    • 84861684871 scopus 로고    scopus 로고
    • Transcriptional profiling of human brain endothelial cells reveals key properties crucial for predictive in vitro blood-brain barrier models
    • Arai K, editor
    • Urich E, Lazic SE, Molnos J, et al. Transcriptional profiling of human brain endothelial cells reveals key properties crucial for predictive in vitro blood-brain barrier models. In: Arai K, editor. PLoS One 2012;7:e38149
    • (2012) PLoS One , vol.7 , pp. e38149
    • Urich, E.1    Lazic, S.E.2    Molnos, J.3
  • 50
    • 84864874302 scopus 로고    scopus 로고
    • Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells
    • Lippmann ES, Azarin SM, Kay JE, et al. Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells. Nat Biotechnol 2012;30:783-91
    • (2012) Nat Biotechnol , vol.30 , pp. 783-791
    • Lippmann, E.S.1    Azarin, S.M.2    Kay, J.E.3
  • 51
    • 84894641836 scopus 로고    scopus 로고
    • A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources
    • Lippmann ES, Al-Ahmad A, Azarin SM, et al. A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources. Sci Rep 2014;4:4160
    • (2014) Sci Rep , vol.4 , pp. 4160
    • Lippmann, E.S.1    Al-Ahmad, A.2    Azarin, S.M.3
  • 52
    • 0020081135 scopus 로고
    • Electrical resistance of brain microvascular endothelium
    • Crone C, Olesen SP. Electrical resistance of brain microvascular endothelium. Brain Res 1982;241:49-55
    • (1982) Brain Res , vol.241 , pp. 49-55
    • Crone, C.1    Olesen, S.P.2
  • 53
    • 0025048342 scopus 로고
    • Electrical resistance across the bloodbrain barrier in anaesthetized rats: A developmental study
    • Butt AM, Jones HC, Abbott NJ. Electrical resistance across the bloodbrain barrier in anaesthetized rats: a developmental study. J Physiol 1990;429:47-62
    • (1990) J Physiol , vol.429 , pp. 47-62
    • Butt, A.M.1    Jones, H.C.2    Abbott, N.J.3
  • 54
    • 84903316132 scopus 로고    scopus 로고
    • A stable and reproducible human bloodbrain barrier model derived from hematopoietic stem cells
    • Cecchelli R, Aday S, Sevin E, et al. A stable and reproducible human bloodbrain barrier model derived from hematopoietic stem cells. PLoS One 2014;9:e99733
    • (2014) PLoS One , vol.9 , pp. e99733
    • Cecchelli, R.1    Aday, S.2    Sevin, E.3
  • 55
    • 84894243243 scopus 로고    scopus 로고
    • Instruction of circulating endothelial progenitors in vitro towards specialized blood-brain barrier and arterial phenotypes
    • Boyer-Di Ponio J, El-Ayoubi F, Glacial F, et al. Instruction of circulating endothelial progenitors in vitro towards specialized blood-brain barrier and arterial phenotypes. PLoS One 2014;9:e84179
    • (2014) PLoS One , vol.9 , pp. e84179
    • Boyer-Di Ponio, J.1    El-Ayoubi, F.2    Glacial, F.3
  • 56
    • 79959952037 scopus 로고    scopus 로고
    • Physiologic and anatomic characterization of the brain surface glia barrier of Drosophila
    • DeSalvo MK, Mayer N, Mayer F, Bainton RJ. Physiologic and anatomic characterization of the brain surface glia barrier of Drosophila. Glia 2011;59:1322-40
    • (2011) Glia , vol.59 , pp. 1322-1340
    • Desalvo, M.K.1    Mayer, N.2    Mayer, F.3    Bainton, R.J.4
  • 57
    • 84895072784 scopus 로고    scopus 로고
    • Zebrafish approaches enhance the translational research tackle box
    • Pickart MA, Klee EW. Zebrafish approaches enhance the translational research tackle box. Transl Res 2014;163:65-78
    • (2014) Transl Res , vol.163 , pp. 65-78
    • Pickart, M.A.1    Klee, E.W.2
  • 58
    • 77956674943 scopus 로고    scopus 로고
    • Claudin-5a in developing zebrafish brain barriers: Another brick in the wall
    • Abdelilah-Seyfried S. Claudin-5a in developing zebrafish brain barriers: another brick in the wall. Bioessays 2010;32:768-76
    • (2010) Bioessays , vol.32 , pp. 768-776
    • Abdelilah-Seyfried, S.1
  • 59
    • 79951882202 scopus 로고    scopus 로고
    • Zebrafish model of the blood-brain barrier: Morphological and permeability studies
    • Eliceiri BP, Gonzalez AM, Baird A. Zebrafish model of the blood-brain barrier: morphological and permeability studies. Methods Mol Biol 2011;686:371-8
    • (2011) Methods Mol Biol , vol.686 , pp. 371-378
    • Eliceiri, B.P.1    Gonzalez, A.M.2    Baird, A.3
  • 60
    • 84863376198 scopus 로고    scopus 로고
    • Galanin transgenic mice with elevated circulating galanin levels alleviate demyelination in a cuprizone-induced MS mouse model
    • Zhang L, Yu W, Schroedter I, et al. Galanin transgenic mice with elevated circulating galanin levels alleviate demyelination in a cuprizone-induced MS mouse model. PLoS One 2012;7:e33901
    • (2012) PLoS One , vol.7 , pp. e33901
    • Zhang, L.1    Yu, W.2    Schroedter, I.3
  • 61
    • 84867874859 scopus 로고    scopus 로고
    • Zebrafish as a model to study drug transporters at the blood-brain barrier
    • Umans RA, Taylor MR. Zebrafish as a model to study drug transporters at the blood-brain barrier. Clin Pharmacol Ther 2012;92:567-70
    • (2012) Clin Pharmacol Ther , vol.92 , pp. 567-570
    • Umans, R.A.1    Taylor, M.R.2
  • 62
    • 84885739130 scopus 로고    scopus 로고
    • Functional characterisation of the maturation of the blood-brain barrier in larval zebrafish
    • Fleming A, Diekmann H, Goldsmith P. Functional characterisation of the maturation of the blood-brain barrier in larval zebrafish. PLoS One 2013;8:e77548
    • (2013) PLoS One , vol.8 , pp. e77548
    • Fleming, A.1    Diekmann, H.2    Goldsmith, P.3
  • 63
    • 84899909435 scopus 로고    scopus 로고
    • Zebrafish models for translational neuroscience research: From tank to bedside
    • Stewart AM, Braubach O, Spitsbergen J, et al. Zebrafish models for translational neuroscience research: from tank to bedside. Trends Neurosci 2014;37:264-78
    • (2014) Trends Neurosci , vol.37 , pp. 264-278
    • Stewart, A.M.1    Braubach, O.2    Spitsbergen, J.3
  • 64
    • 84864948753 scopus 로고    scopus 로고
    • In vivo assessment of the permeability of the blood-brain barrier and blood-retinal barrier to fluorescent indoline derivatives in zebrafish
    • Watanabe K, Nishimura Y, Nomoto T, et al. In vivo assessment of the permeability of the blood-brain barrier and blood-retinal barrier to fluorescent indoline derivatives in zebrafish. BMC Neurosci 2012;13:101
    • (2012) BMC Neurosci , vol.13 , pp. 101
    • Watanabe, K.1    Nishimura, Y.2    Nomoto, T.3
  • 65
    • 84904264611 scopus 로고    scopus 로고
    • Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: A review
    • Bicker J, Alves G, Fortuna A, Falcão A. Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: a review. Eur J Pharm Biopharm 2014;87:409-32
    • (2014) Eur J Pharm Biopharm , vol.87 , pp. 409-432
    • Bicker, J.1    Alves, G.2    Fortuna, A.3    Falcão, A.4
  • 66
    • 0000545811 scopus 로고
    • An in situ brain perfusion technique to study cerebrovascular transport in the rat
    • Takasato Y, Rapoport SI, Smith QR. An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am J Physiol 1984;247:H484-93
    • (1984) Am J Physiol , vol.247 , pp. H484-H493
    • Takasato, Y.1    Rapoport, S.I.2    Smith, Q.R.3
  • 67
    • 0642311330 scopus 로고    scopus 로고
    • In situ brain perfusion technique
    • Smith QR, Allen DD. In situ brain perfusion technique. Methods Mol Med 2003;89:209-18
    • (2003) Methods Mol Med , vol.89 , pp. 209-218
    • Smith, Q.R.1    Allen, D.D.2
  • 68
    • 12344321374 scopus 로고    scopus 로고
    • Involvement of P-glycoprotein in bloodbrain barrier transport of pentazocine in rats using brain uptake index method
    • Moriki Y, Suzuki T, Fukami T, et al. Involvement of P-glycoprotein in bloodbrain barrier transport of pentazocine in rats using brain uptake index method. Biol Pharm Bull 2004;27:932-5
    • (2004) Biol Pharm Bull , vol.27 , pp. 932-935
    • Moriki, Y.1    Suzuki, T.2    Fukami, T.3
  • 69
    • 26844558032 scopus 로고    scopus 로고
    • Quantitation and localization of blood-to-brain influx by magnetic resonance imaging and quantitative autoradiography in a model of transient focal ischemia
    • Knight RA, Nagaraja TN, Ewing JR, et al. Quantitation and localization of blood-to-brain influx by magnetic resonance imaging and quantitative autoradiography in a model of transient focal ischemia. Magn Reson Med 2005;54:813-21
    • (2005) Magn Reson Med , vol.54 , pp. 813-821
    • Knight, R.A.1    Nagaraja, T.N.2    Ewing, J.R.3
  • 70
    • 0030806636 scopus 로고    scopus 로고
    • Methodological considerations of intracerebral microdialysis in pharmacokinetic studies on drug transport across the blood-brain barrier
    • De Lange EC, Danhof M, de Boer AG, Breimer DD. Methodological considerations of intracerebral microdialysis in pharmacokinetic studies on drug transport across the blood-brain barrier. Brain Res Brain Res Rev 1997;25:27-49
    • (1997) Brain Res Brain Res Rev , vol.25 , pp. 27-49
    • De Lange, E.C.1    Danhof, M.2    De Boer, A.G.3    Breimer, D.D.4
  • 71
    • 0034672528 scopus 로고    scopus 로고
    • The use of microdialysis in CNS drug delivery studies. Pharmacokinetic perspectives and results with analgesics and antiepileptics
    • Hammarlund-Udenaes M. The use of microdialysis in CNS drug delivery studies. Pharmacokinetic perspectives and results with analgesics and antiepileptics. Adv Drug Deliv Rev 2000;45:283-94
    • (2000) Adv Drug Deliv Rev , vol.45 , pp. 283-294
    • Hammarlund-Udenaes, M.1
  • 72
    • 38849136513 scopus 로고    scopus 로고
    • CSF as a surrogate for assessing CNS exposure: An industrial perspective
    • Lin JH. CSF as a surrogate for assessing CNS exposure: an industrial perspective. Curr Drug Metab 2008;9:46-59
    • (2008) Curr Drug Metab , vol.9 , pp. 46-59
    • Lin, J.H.1
  • 73
    • 0036349375 scopus 로고    scopus 로고
    • Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: Implications of the barriers between blood and brain
    • De Lange ECM, Danhof M. Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain. Clin Pharmacokinet 2002;41:691-703
    • (2002) Clin Pharmacokinet , vol.41 , pp. 691-703
    • De Lange, E.C.M.1    Danhof, M.2
  • 74
    • 65249143425 scopus 로고    scopus 로고
    • Dynamic analysis of the blood-brain barrier disruption in experimental stroke using time domain in vivo fluorescence imaging
    • Abulrob A, Brunette E, Slinn J, et al. Dynamic analysis of the blood-brain barrier disruption in experimental stroke using time domain in vivo fluorescence imaging. Mol Imaging 2008;7:248-62
    • (2008) Mol Imaging , vol.7 , pp. 248-262
    • Abulrob, A.1    Brunette, E.2    Slinn, J.3
  • 75
    • 33644758151 scopus 로고    scopus 로고
    • Methods to assess drug permeability across the blood-brain barrier
    • Nicolazzo JA, Charman SA, Charman WN. Methods to assess drug permeability across the blood-brain barrier. J Pharm Pharmacol 2006;58:281-93
    • (2006) J Pharm Pharmacol , vol.58 , pp. 281-293
    • Nicolazzo, J.A.1    Charman, S.A.2    Charman, W.N.3
  • 76
    • 84872193339 scopus 로고    scopus 로고
    • Imaging bloodbrain barrier dysfunction in animal disease models
    • Wunder A, Schoknecht K, Stanimirovic DB, et al. Imaging bloodbrain barrier dysfunction in animal disease models. Epilepsia 2012;53(Suppl 6):14-21
    • (2012) Epilepsia , vol.53 , pp. 14-21
    • Wunder, A.1    Schoknecht, K.2    Stanimirovic, D.B.3
  • 78
    • 84907982724 scopus 로고    scopus 로고
    • Engineering and pharmacology of blood-brain barrier-permeable bispecific antibodies
    • Stanimirovic DB, Kemmerich K, Haqqani AS, Farrington GK. Engineering and pharmacology of blood-brain barrier-permeable bispecific antibodies. Adv Pharmacol 2014;71:301-5
    • (2014) Adv Pharmacol , vol.71 , pp. 301-305
    • Stanimirovic, D.B.1    Kemmerich, K.2    Haqqani, A.S.3    Farrington, G.K.4
  • 79
    • 79956337554 scopus 로고    scopus 로고
    • How well can in vitro brain microcapillary endothelial cell models predict rodent in vivo blood-brain barrier permeability?
    • Avdeef A. How well can in vitro brain microcapillary endothelial cell models predict rodent in vivo blood-brain barrier permeability? Eur J Pharm Sci 2011;43:109-24
    • (2011) Eur J Pharm Sci , vol.43 , pp. 109-124
    • Avdeef, A.1
  • 80
    • 77957736634 scopus 로고    scopus 로고
    • Validation of in vitro cell-based human blood-brain barrier model using clinical positron emission tomography radioligands to predict in vivo human brain penetration
    • Mabondzo A, Bottlaender M, Guyot A-C, et al. Validation of in vitro cell-based human blood-brain barrier model using clinical positron emission tomography radioligands to predict in vivo human brain penetration. Mol Pharm 2010;7:1805-15
    • (2010) Mol Pharm , vol.7 , pp. 1805-1815
    • Mabondzo, A.1    Bottlaender, M.2    Guyot, A.-C.3
  • 81
    • 84895778441 scopus 로고    scopus 로고
    • Mechanistic understanding of brain drug disposition to optimize the selection of potential neurotherapeutics in drug discovery
    • Loryan I, Sinha V, Mackie C, et al. Mechanistic understanding of brain drug disposition to optimize the selection of potential neurotherapeutics in drug discovery. Pharm Res 2014;31(8):2203-19
    • (2014) Pharm Res , vol.31 , Issue.8 , pp. 2203-2219
    • Loryan, I.1    Sinha, V.2    MacKie, C.3
  • 82
    • 84855597543 scopus 로고    scopus 로고
    • Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier
    • 1st edition. Elsevier Inc.
    • Pardridge WM, Boado RJ. Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier. Methods Enzymol. 1st edition. Elsevier Inc; 2012. pp 269-92
    • (2012) Methods Enzymol , pp. 269-292
    • Pardridge, W.M.1    Boado, R.J.2
  • 83
    • 84877292573 scopus 로고    scopus 로고
    • Diffusion of macromolecules in the brain: Implications for drug delivery
    • Wolak DJ, Thorne RG. Diffusion of macromolecules in the brain: implications for drug delivery. Mol Pharm 2013;10:1492-504
    • (2013) Mol Pharm , vol.10 , pp. 1492-1504
    • Wolak, D.J.1    Thorne, R.G.2
  • 84
    • 84908002106 scopus 로고    scopus 로고
    • A novel platform for engineering blood-brain barrier-crossing bispecific biologics
    • Farrington GK, Caram-Salas N, Haqqani AS, et al. A novel platform for engineering blood-brain barrier-crossing bispecific biologics. FASEB J 2014;doi:10.1096/fj.14-253369
    • (2014) FASEB J
    • Farrington, G.K.1    Caram-Salas, N.2    Haqqani, A.S.3
  • 85
    • 34547642139 scopus 로고    scopus 로고
    • Blood-brain barrier transport of therapeutics via receptor-mediation
    • Jones AR, Shusta E V. Blood-brain barrier transport of therapeutics via receptor-mediation. Pharm Res 2007;24:1759-71
    • (2007) Pharm Res , vol.24 , pp. 1759-1771
    • Jones, A.R.1    Shusta, E.V.2
  • 86
    • 34547637590 scopus 로고    scopus 로고
    • Drug targeting to the brain
    • Pardridge WM. Drug targeting to the brain. Pharm Res 2007;24:1733-44
    • (2007) Pharm Res , vol.24 , pp. 1733-1744
    • Pardridge, W.M.1
  • 87
    • 0642342122 scopus 로고    scopus 로고
    • Phage display technology for identifying specific antigens on brain endothelial cells
    • Tanha J, Muruganandam A, Stanimirovic D. Phage display technology for identifying specific antigens on brain endothelial cells. Methods Mol Med 2003;89:435-49
    • (2003) Methods Mol Med , vol.89 , pp. 435-449
    • Tanha, J.1    Muruganandam, A.2    Stanimirovic, D.3
  • 88
    • 28244432240 scopus 로고    scopus 로고
    • The blood-brain barrier transmigrating single domain antibody: Mechanisms of transport and antigenic epitopes in human brain endothelial cells
    • Abulrob A, Sprong H, Van Bergen en Henegouwen P, Stanimirovic D. The blood-brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cells. J Neurochem 2005;95:1201-14
    • (2005) J Neurochem , vol.95 , pp. 1201-1214
    • Abulrob, A.1    Sprong, H.2    Van Bergen-En-Henegouwen, P.3    Stanimirovic, D.4
  • 89
    • 84877255599 scopus 로고    scopus 로고
    • Multiplexed evaluation of serum and CSF pharmacokinetics of braintargeting single-domain antibodies using a NanoLC-SRM-ILIS method
    • Haqqani AS, Caram-Salas N, Ding W, et al. Multiplexed evaluation of serum and CSF pharmacokinetics of braintargeting single-domain antibodies using a NanoLC-SRM-ILIS method. Mol Pharm 2013;10:1542-56
    • (2013) Mol Pharm , vol.10 , pp. 1542-1556
    • Haqqani, A.S.1    Caram-Salas, N.2    Ding, W.3
  • 90
    • 0035997330 scopus 로고    scopus 로고
    • Prediction of drug transport through the blood-brain barrier in vivo: A comparison between two in vitro cell models
    • Lundquist S, Renftel M, Brillault J, et al. Prediction of drug transport through the blood-brain barrier in vivo: a comparison between two in vitro cell models. Pharm Res 2002;19:976-81
    • (2002) Pharm Res , vol.19 , pp. 976-981
    • Lundquist, S.1    Renftel, M.2    Brillault, J.3
  • 91
    • 2942623871 scopus 로고    scopus 로고
    • Evidence for bulk flow of brain interstitial fluid: Significance for physiology and pathology
    • Abbott NJ. Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochem Int 2004;45:545-52
    • (2004) Neurochem Int , vol.45 , pp. 545-552
    • Abbott, N.J.1
  • 92
    • 84898433336 scopus 로고    scopus 로고
    • Neonatal Fc receptor (FcRn): A novel target for therapeutic antibodies and antibody engineering
    • Wang Y, Tian Z, Thirumalai D, Zhang X. Neonatal Fc receptor (FcRn): a novel target for therapeutic antibodies and antibody engineering. J Drug Target 2014;22:269-78
    • (2014) J Drug Target , vol.22 , pp. 269-278
    • Wang, Y.1    Tian, Z.2    Thirumalai, D.3    Zhang, X.4
  • 93
    • 34347403252 scopus 로고    scopus 로고
    • Drug development for CNS disorders: Strategies for balancing risk and reducing attrition
    • Pangalos MN, Schechter LE, Hurko O. Drug development for CNS disorders: strategies for balancing risk and reducing attrition. Nat Rev Drug Discov 2007;6:521-32
    • (2007) Nat Rev Drug Discov , vol.6 , pp. 521-532
    • Pangalos, M.N.1    Schechter, L.E.2    Hurko, O.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.